XML 35 R21.htm IDEA: XBRL DOCUMENT v3.19.1
15. Parent Company Financial Statements (Unaudited)
12 Months Ended
Dec. 31, 2018
Condensed Financial Information Disclosure [Abstract]  
Parent Company Financial Statements (Unaudited)

The following is a summary of the Parent Company financial statements for the years ended December 31, 2018 and 2017:

 

Aemetis, Inc. (Parent Company)

Balance Sheets

As of December 31, 2018 and 2017

 

Assets   2018     2017  
Current assets            
Cash and cash equivalents   $ -     $ 29  
Receivables due from subsidiaries     5,057       6,946  
Prepaid expenses     364       251  
Total current assets     5,421       7,226  
                 
Investment in AE Advanced Products Keyes , Inc.     1,057       1,617  
Total investments in Subsidiaries, net of advances     1,057       1,617  
                 
Property, plant and equipment, net     12       15  
Other assets     54       54  
                 
Total Assets   $ 6,544     $ 8,912  
                 
Liabilities & stockholders' deficit                
Current liabilities                
Accounts payable   $ 5,026     $ 3,568  
Mandatorily redeemable Series B convertible preferred     3,048       2,946  
GAFI- payables, net of SARs discount issuance costs     1,090       3,357  
SARs liability     1,132       -  
Other current liabilities     2,215       1,679  
Total current liabilities     12,511       11,550  
                 
                 
Subsidiary obligation in excess of investment                
Investment in AE Advanced Fuels, Inc.     89,854       69,273  
Investment in Aemetis Americas, Inc     205       205  
Investment in Aemetis Biofuels, Inc.     2,738       2,738  
Investment in Aemetis Technologies, Inc.     4,030       2,947  
Investment in Aemetis Property Keyes, Inc.     432       100  
Investment in Biofuels Marketing, Inc.     349       349  
Investment in Aemetis International, Inc.     963       142  
Investment in Aemetis Biogas LLC     6,304       -  
Total subsidiary obligation in excess of investment     104,875       75,754  
                 
Stockholders' deficit                
Series B Preferred convertible stock     1       1  
Common stock     20       20  
Additional paid-in capital     85,917       84,679  
Accumulated deficit     (193,204 )     (160,188 )
Accumulated other comprehensive loss     (3,576 )     (2,904 )
Total stockholders' deficit     (110,842 )     (78,392 )
Total liabilities & stockholders' deficit   $ 6,544     $ 8,912  

 

Aemetis, Inc. (Parent Company)

Statements of Operations and Comprehensive Loss

For the Years Ended December 31, 2018 and 2017

 

    2018     2017  
             
Equity in subsidiary losses   $ (29,009 )   $ (22,341 )
                 
Selling, general and administrative expenses     8,742       7,317  
                 
Operating loss     (37,751 )     (29,658 )
                 
Other expense                
Interest expense     1,281       503  
Other (income) expense     (6,023 )     134  
                 
 Loss before income taxes     (33,009 )     (30,295 )
                 
Income tax expense     7       6  
                 
Net loss     (33,016 )     (30,301 )
                 
Other comprehensive loss                
Foreign currency translation adjustment     (672 )     484  
Comprehensive loss   $ (33,688 )   $ (29,817 )

 

Aemetis, Inc. (Parent Company)

Statements of Cash Flows

For the years ended December 31, 2018 and 2017

 

    2018     2017  
Operating activities:            
Net loss     (33,016 )     (30,301 )
Adjustments to reconcile net loss to net cash used in operating activities:                
                 
Stock-based compensation     981       1,101  
Stock issued for services     22       118  
SARs Amortization      477       -  
Depreciation     8       6  
Subsidiary portion of net losses     29,009       22,341  
Change in fair value of SARs liability     (145 )        
Changes in assets and liabilities:                
Prepaid expenses     (113 )     19  
Accounts payable     1,459       529  
Accrued interest expense     209       503  
Other liabilities     275       64  
Net cash used in operating activities     (834 )     (5,620 )
                 
Investing activities:                
Subsidiary advances, net     2,119       5,149  
Net cash provided by investing activities     2,119       5,149  
                 
Financing activities:                
Proceeds from borrowings under secured debt facilities     1,500       500  
Repayments of borrowings under secured debt facilities     (2,814 )     -  
Net cash (used)/provided by financing activities     (1,314 )     500  
                 
Net increase (decrease) in cash and cash equivalents     (29 )     29  
                 
Cash and cash equivalents at beginning of period     29       -  
Cash and cash equivalents at end of period   $ -     $ 29  
                 
Supplemental disclosures of cash flow information, cash paid:                
                 
Interest payments     -       -  
Income tax expense     7       6  
                 
Supplemental disclosures of cash flow information, non-cash transactions:                
                 
Fair value of warrants issued to subordinated debt holders     235       321  
Repurchase of common stock added to TEC promissory note     -       451  
Payment of TEC bridge loan added to GAFI Revolving loan     -       3,669  
Stock Appreciation Rights issued for GAFI Amendment No. 1     1,277       -  
Settlement of subordinated debt through issuing stock     -       132